Site icon

Malaria Diagnostics Market Poised to Expand at a Robust Pace by 2025

Patient on hospital bed

Global Malaria Diagnostics Market: Overview

According to the WHO, around 203 million cases of malaria was reported worldwide in 2012. The same year malaria resulted in approximately 627,000 deaths around the world. In order to curb the spread of malaria governments, especially in underdeveloped and developing countries, are leaving no stone unturned. Advanced diagnosis for malaria detection is thus encouraged. Incentives are offered as well to make them available at a pocket-friendly or nominal price in people living across remote regions.

Early and precise diagnosis can help in the treatment of malaria and ensure rapid discovery. The malaria diagnostics market has therefore witnessed rise in investments in various diagnostic techniques. These involve the detection of malaria with the help of microscopy and blood tests. Malaria diagnosis is conducted using various techniques such as molecular diagnostics, rapid diagnostic tests (RDTs), and by detecting the presence of parasites using microscopy.

The report provides a comprehensive overview of the global malaria diagnostics market covering growth drivers and restraints influencing its trajectory between 2013 and 2019. It segments the market based on various parameters and studies the factors influencing its growth across these segments. The report also studies the effect of Porter’s five forces on the overall market operations.

Request a PDF Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1972

Global Malaria Diagnostics Market: Trends and Opportunities

The advent of advanced technologies has revolutionized malaria diagnosis and are high in demand. These tests have proven successful in detecting antigens of malaria parasites. As government funding for the healthcare industry rise, coupled with the increasing investment in research and development of novel therapeutics, the demand in the malaria diagnostics market is projected to rise in response.

Some of the most common techniques used in the detection of malaria are QBC technique, peripheral blood smears, and serological tests. Besides this, drugs most commonly administered for the treatment of malaria are artemether-lumefantrine (Coartem), atovaquone-proguanil (Malarone), clindamycin used in combination with quinine, chloroquine, quinine, mefloquine (Lariam), and quinidine. Factors influencing the demand of these drug classes are analyzed as well. The report also studies the impact of the looming patent expiry of blockbuster drugs on the global malaria diagnostics market. On the flip side, technological complications present in a few of the commonly used diagnostic methods could restrain the market’s expansion to an extent.

Global Malaria Diagnostics Market: Regional Outlook

Regionally, Europe, North America, Asia Pacific, and Rest of the World constitute the key segments in the global malaria diagnostics market. Among these, the market is expected to witness exponentially high demand in Europe and Asia Pacific as these regions exhibit a high prevalence of malaria. Besides this, steps taken by government to spread awareness regarding the diseases, its treatment, and prevention are expected to give the malaria diagnostics market significant impetus. This scenario will be most prevalent across emerging nations in Asia Pacific and Rest of the World. For instance, the Indian government has been significantly investing in creating awareness about the prevention and cure of malaria. The country is also exhibiting rising healthcare expenditure. These factors are expected to create lucrative opportunities fo9r the malaria diagnostics market in Asia Pacific.

Request for Analysis of COVID19 Impact on Malaria Diagnostics Markethttps://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1972

Global Malaria Diagnostics Market: Vendor Landscape

Some of the leading companies operating in the global malaria diagnostics market are bioMerieux,

Beckman Coulter/Danaher, Abbott Laboratories, Bio-Rad Laboratories, Inc., Novartis Diagnostics, Life Technology, Siemens Healthcare, Bio-Rad, Ortho-Clinical Diagnostics, and Wako Chemicals, Inc.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers’ or customers’ journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

Purchase Malaria Diagnostics Market Reporthttps://www.transparencymarketresearch.com/checkout.php?rep_id=1972&ltype=S

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com

Read More Reports: https://www.prnewswire.co.uk/news-releases/consistently-high-demand-for-immunoglobulin-igm-replacement-therapy-for-antibody-deficiency-to-unlock-substantial-revenue-potential-in-primary-immunodeficiency-market-during-2020-2028-finds-tmr-893195759.html

 

 

Exit mobile version